Scientists at Duke University School of Medicine are developing a new CAR-T cell therapy that could finally help immunotherapy take aim at solid tumors. Early tests look promising, and it started with one patient’s immune system doing something extraordinary.

The Duke Clinical and Translational Science Institute (CTSI) and Duke Health mourn the passing of David H. Murdock, a visionary philanthropist and the namesake of the MURDOCK Study, who died at the age of 102.

The new facility will add hospital services to the existing Duke Health Cary location, including an emergency room, surgical services, imaging, cancer treatments, and other care.